We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




An Omics Approach for Predicting Mutations in Protein-Metal Binding Sites

By LabMedica International staff writers
Posted on 06 Jan 2020
Print article
Image: Cartoon representation of the zinc-finger motif of proteins. The zinc ion (green) is coordinated by two histidine and two cysteine amino acid residues (Photo courtesy of Wikimedia Commons)
Image: Cartoon representation of the zinc-finger motif of proteins. The zinc ion (green) is coordinated by two histidine and two cysteine amino acid residues (Photo courtesy of Wikimedia Commons)
A deep learning approach was developed that was able to predict how mutations in the metal-binding sites of metalloproteins were related to various diseases.

Metalloproteins play important roles in many biological processes. Mutations at the metal-binding sites may functionally disrupt metalloproteins, initiating severe diseases; however, there has not been an effective approach for predicting such mutations.

In this regard, investigators at the University of Hong Kong (China) developed an “omics”-based deep learning approach to predict disease-associated mutations of the metal-binding sites in a protein. Omics (such fields as genomics, proteomics, etc.) aims at the collective characterization and quantification of pools of biological molecules that translate into the structure, function, and dynamics of an organism or organisms.

The investigators began by integrating omics data from different databases to build a comprehensive computer training dataset. Statistical analysis of the collected data revealed that various metals had different disease associations. A mutation in zinc-binding sites had a major role in breast, liver, kidney, immune system, and prostate diseases. By contrast, mutations in calcium- and magnesium-binding sites were associated with muscular and immune system diseases, respectively. Mutations in iron-binding sites were associated with metabolic diseases. In addition, mutations of manganese- and copper-binding sites were associated with cardiovascular diseases, and copper-binding site mutations were also associated with nervous system diseases.

The investigators generated energy-based affinity grid maps and physiochemical features of the metal-binding pockets (obtained from different databases as spatial and sequential features) and subsequently incorporated these features into a multichannel convolutional neural network. After training the model, the multichannel convolutional neural network successfully predicted disease-associated mutations that occurred at the first and second coordination spheres of zinc-binding sites with an area under the curve of 0.90 and an accuracy of 0.82.

Senior author Dr. Hongzhe Sun, professor of bioinorganic chemistry at the University of Honk Kong, said, "Machine learning and AI play important roles in the current biological and chemical science. In my group we worked on metals in biology and medicine using integrative omics approach including metallomics and metalloproteomics, and we already produced a large amount of valuable data using in vivo/vitro experiments. We now develop an artificial intelligence approach based on deep learning to turn these raw data to valuable knowledge, leading to uncover secrets behind the diseases and to fight with them. I believe this novel deep learning approach can be used in other projects, which is undergoing in our laboratory."

The mettaloprotein binding site mutations paper was published in the December 9, 2019, online edition of the journal Nature Machine Intelligence.

Related Links:
University of Hong Kong

New
Gold Member
LEISHMANIA Test
LEISHMANIA ELISA
New
Gold Member
Chagas Disease Test
CHAGAS Cassette
New
Refrigerated Microtube Homogenizer
BeadBlaster 24R
New
PROM Test
AMNIOQUICK DUO

Print article

Channels

Immunology

view channel
Image: The discovery of biomarkers could improve endometrial cancer treatment (Photo courtesy of Mount Sinai)

Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer

Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read more

Pathology

view channel
Image: As tumor cells flow through these microfluidic chambers, they are subjected to increasing shear stress and sorted based on their adhesion strength (Photo courtesy of UC San Diego)

Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread

Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.